Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123714732 | 12371473 | 2 | F | 20160823 | 20160516 | 20160906 | EXP | US-ROCHE-1756698 | ROCHE | 62.00 | YR | M | Y | 72.60000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123714732 | 12371473 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | 125085 | |||||||||||
123714732 | 12371473 | 2 | SS | IPILIMUMAB | IPILIMUMAB | 1 | Unknown | 0 | 224 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123714732 | 12371473 | 1 | Malignant melanoma |
123714732 | 12371473 | 2 | Malignant melanoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123714732 | 12371473 | OT |
123714732 | 12371473 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123714732 | 12371473 | Acute respiratory distress syndrome | |
123714732 | 12371473 | Death | |
123714732 | 12371473 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123714732 | 12371473 | 2 | 20150730 | 0 |